Lido Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.21M Sell
12,862
-14,615
-53% -$3.88M 0.02% 452
2026
Q1
$3.01M Buy
27,477
+15,180
+123% +$2.16M 0.01% 584
2025
Q4
$2.4M Buy
12,297
+57
+0.5% +$9.54K 0.01% 669
2025
Q3
$2.4M Sell
12,240
-4,550
-27% -$748K 0.01% 634
2025
Q2
$1.52M Buy
16,790
+879
+6% +$69.4K 0.01% 681
2025
Q1
$949K Buy
15,911
+1,899
+14% +$176K ﹤0.01% 803
2024
Q4
$1.86M Buy
14,012
+5,986
+75% +$562K 0.01% 537
2024
Q3
$420K Buy
+8,026
New +$377K ﹤0.01% 1011

Other funds holding ALAB

Lido Advisors's ALAB Position: Q2 2026 in Review

Lido Advisors reduced its Astera Labs (ALAB) stake by 53% in Q2 2026, selling an estimated $3.88M and leaving 12,862 shares worth $6.21M. The position accounts for 0.02% of the portfolio, ranked #452.

Lido Advisors first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Lido Advisors held 12,862 shares of Astera Labs worth $6.21M as of Q2 2026.
  • Lido Advisors sold 14,615 Astera Labs shares in Q2 2026, an estimated $3.88M.
  • Astera Labs made up 0.02% of Lido Advisors's portfolio in Q2 2026, its #452 holding.
  • Lido Advisors first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.